Cybersecurity sits at the center of every boardroom conversation these days. AI has turbocharged both threats and defenses, pushing the sector toward $500 billion in annual spending by decade’s end. Yet many leading stocks have traded sideways or dipped amid broader market jitters and slowing growth elsewhere in tech.
CrowdStrike (NASDAQ:CRWD | CRWD Price Prediction) just stepped up with a move that cuts through the noise. This morning, the company announced it added $500 million to its share repurchase program, lifting the total authorization to $1.5 billion. Ever notice how a business hitting record milestones can still leave investors questioning the stock price? That gap is exactly what management just highlighted. Let’s unpack why this buyback matters for your portfolio.
The Buyback That Speaks Volumes
CrowdStrike’s board’s extra $500 million repurchase authority comes with no fixed expiration or minimum purchase obligation attached. The company already put $150.6 million to work, buying 413,130 shares at an average price of $364.57 after its record fourth quarter.
CFO Burt Podbere laid it out plainly in the press release: the move addresses “a growing disconnect between our improving momentum fueled by AI tailwinds and our current valuation.” In short, executives see the stock as mispriced relative to the business trajectory. Repurchases return capital opportunistically while signaling confidence without committing to a rigid schedule. That flexibility matters in a sector where timing can swing on one big contract or macro shift.
Regardless of your view, spending real cash at these levels shows management believes shares trade below intrinsic value today.
The Business Momentum Investors Should See
CrowdStrike’s fiscal 2026 results paint a picture of accelerating scale. Full-year revenue reached $4.81 billion, up 22% from $3.95 billion the prior year. Fourth-quarter revenue rose 23% year-over-year to $1.31 billion, with subscription revenue up 23% to $1.24 billion.
Annual recurring revenue (ARR) hit $5.25 billion, up 24% year-over-year and the first time it crossed the $5 billion mark for any pure-play cybersecurity software firm. Net new ARR in the quarter alone set a record at $330.7 million, up 47% while full-year net new ARR topped $1.01 billion for the first time. Free cash flow for the year totaled $1.24 billion — or 26% of revenue — while the fourth quarter delivered $376.4 million at a 29% margin. The company even posted its first positive GAAP net income in the quarter: $38.7 million.
That’s a fancy way of saying the Falcon platform, Falcon Flex deals, and AI integrations are driving durable, profitable expansion toward the long-term $20 billion ARR target by fiscal 2036.
How CrowdStrike Stacks Up Against Cybersecurity Peers
Growth stocks never exist in a vacuum, so let’s line up the numbers of some of CrowdStrike’s peers:
| Metric | CrowdStrike |
Palo Alto Networks (NASDAQ:PANW) |
Zscaler (NASDAQ:ZS) |
| Latest quarterly revenue growth | 23% | 15% | 26% |
| Forward P/E | 64x | 40x | 30x |
| Annual recurring revenue growth | 24% | 33% | 22% |
| Free cash flow margin (recent) | 26% | 37% | 21% |
Source: Data compiled from each company’s most recent earnings releases and Yahoo Finance key statistics.
CrowdStrike trades at a premium on the forward P/E multiple, yet it delivers fast ARR expansion and higher cash conversion than ZScaler while matching or beating Palo Alto’s growth profile. Granted, the richer valuation leaves less margin for error if AI adoption slows. That said, the company’s cloud-native architecture and platform consolidation edge give it a structural advantage its rivals still chase.
Key Takeaway
CrowdStrike’s expanded $1.5 billion repurchase program is management’s clearest vote yet that the stock undervalues its AI-fueled business momentum. At current levels near $397, the forward P/E of 82x looks elevated next to peers, but the record $1.24 billion in free cash flow and 24% ARR growth provide the cash to keep buying back shares opportunistically.
Savvy investors should view this disconnect as an entry signal for a high-quality compounder. Still, the stock’s premium — even with its superior growth profile — says don’t go all-in yet. Watch the upcoming Q1 fiscal 2027 update for CrowdStrike’s ARR guidance, and wait for any dip to buy more. When all is said and done, the numbers show a business built to last far beyond today’s valuation debate.